View Older Stories View More Recent Stories

Sep 21, 2022 07:00AM Axsome Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
Sep 20, 2022 12:00PM Salarius Pharmaceuticals to Present at the 2022 Ladenburg Thalmann Healthcare Conference
Sep 19, 2022 04:01PM Rhythm Pharmaceuticals, Inc. Announces Closing of $124.8 Million Public Offering
Sep 19, 2022 04:01PM Energous Presenting to Investors at Ladenburg Thalmann & Co. Inc.
Sep 19, 2022 04:01PM Rhythm Pharmaceuticals, Inc. Announces Closing of $124.8 Million Public Offering
Sep 16, 2022 04:05PM Beyond Air® To Participate in Three Upcoming Investor Conferences
Sep 16, 2022 06:00AM Allarity Therapeutics to Present at Ladenburg Thalmann Healthcare Conference
Sep 16, 2022 06:00AM Allarity Therapeutics to Present at Ladenburg Thalmann Healthcare Conference
Sep 15, 2022 04:32PM SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conference
Sep 15, 2022 07:52AM NeuroBo Pharmaceuticals (NRBO) Reports License Agreement with Dong-A
Sep 15, 2022 05:49AM Rhythm Pharmaceuticals (RYTM) Prices 4.8M Share Offering at $26/sh
Sep 14, 2022 10:20PM Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
Sep 14, 2022 10:20PM Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
Sep 12, 2022 05:55AM Ra Medical Systems (RMED) to Merge with Catheter Precision
Sep 12, 2022 05:50AM Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
Sep 9, 2022 08:30AM SCYNEXIS to Participate in Upcoming September Investor Conferences
Sep 9, 2022 08:01AM NovaBay Pharma (NBY) Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million
Sep 9, 2022 08:00AM NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million
Sep 8, 2022 09:00AM Nanox to Present at Two Upcoming Investor Conferences in September 2022
Sep 8, 2022 09:00AM Nanox to Present at Two Upcoming Investor Conferences in September 2022
Sep 7, 2022 04:00PM UroGen Pharma Announces Upcoming 2022 Conferences
Sep 7, 2022 08:00AM Eyenovia to Present at Upcoming Healthcare Conferences
Sep 7, 2022 08:00AM Achieve Life Sciences Announces Participation at Fall Investor Conferences
Sep 7, 2022 08:00AM Achieve Life Sciences Announces Participation at Fall Investor Conferences
Sep 6, 2022 08:35AM Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
Sep 6, 2022 08:35AM Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
Sep 6, 2022 08:00AM Astria Therapeutics to Present at Upcoming Investment Conferences
Sep 6, 2022 08:00AM electroCore to Participate at Upcoming Investor Conferences
Sep 6, 2022 08:00AM electroCore to Participate at Upcoming Investor Conferences
Sep 6, 2022 08:00AM Ardelyx to Participate in Upcoming Investor Conferences
Sep 6, 2022 07:32AM Cognition Therapeutics Announces Participation in September Investment Conferences
Sep 6, 2022 07:32AM Cognition Therapeutics Announces Participation in September Investment Conferences
Sep 1, 2022 08:00AM Rhythm Pharmaceuticals to Present at Investor Conferences in September
Sep 1, 2022 08:00AM Rhythm Pharmaceuticals to Present at Investor Conferences in September
Sep 1, 2022 06:30AM Immunic, Inc. to Participate in Investor Conferences in September
Aug 31, 2022 01:31PM Liquidia (LQDA) '793 Patent Stay Denial Does Not Change Investment Thesis - Ladenburg Thalmann
Aug 31, 2022 07:27AM UPDATE: Ladenburg Thalmann Starts Satsuma Pharmaceuticals (STSA) at Buy
Aug 31, 2022 06:00AM Bionomics to Participate in Upcoming September Investor Conferences
Aug 30, 2022 04:05PM Alpha Tau Medical to Participate in Upcoming September Investor Conferences
Aug 30, 2022 04:05PM Alpha Tau Medical to Participate in Upcoming September Investor Conferences
Aug 30, 2022 12:00PM CARMAT Announces Participation in Key Investor and Scientific Conferences During the Second Half of 2022
Aug 29, 2022 12:20PM Sachem Capital Corp. Announces Sale of an Additional $5.25 Million of 8.00% Notes Due 2027
Aug 25, 2022 07:03AM UPDATE: Ladenburg Thalmann Starts Kiora Pharmaceuticals (KPRX) at Buy, 'attractive investment opportunity', PT $6.50
Aug 23, 2022 11:30AM Sachem Capital Corp. Announces Closing of Public Offering of $35.0 Million of 8.00% Notes
Aug 23, 2022 06:42AM UPDATE: Ladenburg Thalmann Downgrades Allarity Therapeutics Inc. (ALLR) to Neutral
Aug 22, 2022 09:00AM Usio Announces Hiring of Paul Manley as Head of Investor Relations
Aug 22, 2022 06:00AM Advisor Group Welcomes Brian Falconer with $203 Million in Assets to its Platform
Aug 17, 2022 05:41PM Sachem Capital Corp. (SACH) Prices $35M Registered Notes Offering
Aug 17, 2022 05:40PM Sachem Capital Corp. Prices Registered Public Offering of $35.0 Million 8.00% Notes
Aug 17, 2022 07:32AM Sachem Capital Corp. (SACH) Announces Public Offering of Notes
View More Recent Stories View Older Stories